Enterprise Therapeutics is a drug discovery company dedicated to the research
and development of novel therapies for the treatment of respiratory diseases.

In diseases such as cystic fibrosis, asthma and COPD the lungs become congested with mucus leading to difficulty in breathing. New disease modifying therapies that target the underlying mechanisms of mucus congestion will reduce the frequency of lung infections and improve patient quality of life.


Enterprise Therapeutics will be attending:

> Gordon Research Conference – Cilia, Mucus & Mucociliary Interactions – 12-17 February 2017 Galveston, Texas, USA.

> 14th European Cystic Fibrosis Conference Basic Science Conference – 29 March - 01 April 2017 Albufeira, Portugal.

LinkedIn BIA Member Logo